2 safe FTSE 100 shares with dividend yields above 4%

Are these the best FTSE 100 shares for dividends and safety?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Today, I’m taking a look at two FTSE 100 shares that I believe offer solid long-term dividend growth potential.

Regulated monopoly

First up is National Grid (LSE: NG), the UK’s largest listed utility company. With a relatively low beta of just 0.48, its shares tend to be less volatile than the wider index, which suggest that National Grid is a less risky investment.

One of the biggest advantages for National Grid, and which explains why it has such a low-risk business model, is the exceptionally high initial costs needed to build infrastructure for electricity transmission and gas distribution. This makes National Grid a natural monopoly, which means it faces no competition whatsoever.

Instead, nearly all of its revenues are regulated by Ofgem, via the RIIO regulatory framework, which determines how much the company is allowed to earn on investments made to its infrastructure assets. These revenues are linked to RPI inflation and don’t depend on volumes or commodity prices. This results in the company generating stable earnings and cash flows year-on-year, and means its shares have staying power.

The company is undergoing a major transformation, which should reinforce its status as a ‘shareholder friendly’ company. In December, the company agreed to sell a 61% stake in its gas distribution network, which should allow it to focus on its faster-growing electricity transmission business.

The sale received the green light from the European Commission last week, which means the deal is expected to close in the coming weeks. And once completed, National Grid intends to return £4bn of its net proceeds to shareholders via a combination of a special dividend and share buybacks. Additionally, National Grid’s rate of earnings growth should pick up following the deal, and that would be further good news for dividend investors.

Annual dividends per share have increased more than 60% over the past decade, with a compound annual growth rate (CAGR) of 5.0% over the past 10 years. Looking forward, National Grid has pledged to grow ordinary dividends at least in line with RPI inflation for the foreseeable future, following a share consolidation later this year, intended to reflect its smaller asset base following the sale of its gas network.

At a current price of 995p a share, National Grid has a dividend yield of 4.5%.

Diversified business model

GlaxoSmithKline‘s (LSE: GSK) dividend safety comes from a combination of two factors: the non-cyclical nature of demand for pharmaceutical products and the company’s unique diversified business model.

In addition to the traditional pharmaceutical business, GSK owns a large consumer healthcare businesses, which generates more than a quarter of its revenues, and a sizeable vaccines business, which accounts for another 16% of group revenues. Together, these two businesses account for a growing proportion of GSK’s revenues and a majority of its earnings growth in recent years.

An anticipated 9% earnings rise at GSK this year gives its shares a reasonable forward P/E rating of 15.4 times. And this would fall to 14.7 times in 2018 on forecasts of further earnings improvement of 4%. With an improving earnings outlook and strong diversification, I reckon GSK represents a great pick for long-term income investors.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Jack Tang has no position in any shares mentioned. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Here’s how I’d aim for a ton of passive income from £20k in an ISA

To get the best passive income from an ISA, I think we need to balance risk with the potential rewards.…

Read more »

Abstract bull climbing indicators on stock chart
Investing Articles

2 FTSE 100 stocks I’d buy as the blue-chip index hits record highs

This Fool takes a look at a pair of quality FTSE 100 stocks that appear well-positioned for future gains, despite…

Read more »

Satellite on planet background
Small-Cap Shares

Here’s why AIM stock Filtronic is up 44% today

The share price of AIM stock Filtronic has surged on the back of some big news in relation to its…

Read more »

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

At a record high, there can still be bargain FTSE 100 shares to buy!

The FTSE 100 closed at a new all-time high this week. Our writer explains why there might still be bargain…

Read more »

Asian man looking concerned while studying paperwork at his desk in an office
Investing Articles

After profits plunge 28%, should investors consider buying Lloyds shares?

Lloyds has seen its shares wobble following the release of its latest results. But is this a chance for investors…

Read more »

Abstract bull climbing indicators on stock chart
Investing Articles

Something’s changed in a good way for Reckitt in Q1, and the share price may be about to take off

With the Reckitt share price near 4,475p, is this a no-brainer stock? This long-time Fool takes a closer look at…

Read more »

Investor looking at stock graph on a tablet with their finger hovering over the Buy button
Investing Articles

This new boost in assets might just get the abrdn share price moving again

The abrdn share price has lost half its value in the past five years. But with investor confidence returning, are…

Read more »

Young Black man sat in front of laptop while wearing headphones
Investing Articles

As revenues rise 8%, is the Croda International share price set to bounce back?

The latest update from Croda International indicates that sales are starting to recover from the end of 2023, so is…

Read more »